Hong kong stocks minimally invasive robots rose more than 13%. The company completed the placement of a total of 34.7 million shares, and the net proceeds from the placement were about HK$ 266 million.South Korea's investigation department: The civil unrest emissary can be arrested urgently. On the morning of December 11th, local time, Wu Dongyun, director of the Crime Investigation Department of South Korea's senior public officials, said in an inquiry about the state of "emergency martial law" in the South Korean National Assembly that according to Korean law, the civil unrest emissary can be arrested urgently. On the same day, the South Korean police seized and searched the South Korean Presidential Palace in Longshan District, Seoul. (CCTV News)
Anmai, the liquidator of Evergrande, learned that he had taken over the private jet in Xu Jiayin and sought to put it on the market. Alvarez & Marsal, the liquidator of Evergrande, learned that he had taken over the offshore entity holding the private jet under the name of Xu Jiayin and put it on the market. The 14-year-old Airbus A319, which is about the size of a commercial airliner, is currently parked in Guangzhou. According to the report, the valuation of the aircraft is about 25 million to 30 million US dollars, which is 66.7% to 72% lower than the new valuation of 90 million US dollars. (Interface News)Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Afternoon comment: the three major indexes rose slightly in half a day, and the concept of Shanghai's state-owned enterprise reform lifted the tide of daily limit. The three major indexes opened lower and went higher in early trading and rose slightly in half a day. In terms of sectors, the concept of Shanghai's state-owned enterprise reform is on the rise, and Shanghai Material Trade, First Medicine and Shibei High-tech are collectively on the rise. The retail sector continued to be strong, with the daily limit of Youa, Zhongbai Group and Maoye Commercial. The concept of AI glasses is higher, and Tianjian shares and Star Technology both have a daily limit of 20cm; Insurance stocks continued to adjust, and Tianmao Group fell to an intraday limit; Sora concept stocks collectively adjusted back, and the word Huayang Lianzhong fell; Bank shares fluctuated lower, with Bank of Ningbo leading the decline. Overall, stocks rose more and fell less, with more than 3,500 stocks rising. On the disk, Shanghai's state-owned enterprise reform, AI glasses and retail sectors were among the top gainers, while insurance, Sora concept and banking sectors were among the top losers.Market news: Japan is considering levying a 4% corporate tax surcharge for national defense expenditure.Hanwei Technology and others set up a new company in Hubei, including geographic remote sensing information service business. The enterprise search APP shows that recently, Hubei Hanwei Water Technology Co., Ltd. was established, with Zhao Shuai as the legal representative and a registered capital of 10 million yuan. Its business scope includes: intelligent instrument manufacturing; Industrial automatic control system device manufacturing; Research and development of mechanical equipment; Intelligent control system integration; Internet of things equipment sales; Geographic remote sensing information service, etc. Enterprise survey shows that the company is jointly owned by Hanwei Water Technology (Henan) Co., Ltd. and Li Yuhua, a subsidiary of Hanwei Technology.
Strategy guide
12-14
Strategy guide 12-14